| Literature DB >> 35238368 |
Manikandan Srinivasan1, Kulandaipalayam Natarajan Sindhu1, Atrayee Nag1, Arun S Karthikeyan1, Ranjith Kumar Ramasamy1, Malathi Murugesan1, Dilesh Kumar1, Santhosh Kumar Ganesan1, Winsley Rose2, Gagandeep Kang1, Jacob John3.
Abstract
BACKGROUND: Primary data on causes and costs of hospitalization are necessary for costing and cost-effectiveness analysis. Data on incidence and causes of hospitalization and consequent expenses among Indian children are limited.Entities:
Keywords: India; antibiotics; children; health care; hospitalization; incidence; medical costs
Mesh:
Year: 2021 PMID: 35238368 PMCID: PMC8892546 DOI: 10.1093/infdis/jiab329
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226
Incidence of All-Cause Hospitalization Over a 3-year Period in a Cohort of Children 0.5 to 15 Years of Age Recruited Into a Febrile Surveillance Study in Vellore, Tamil Nadu (n = 6760)
| Variable | n | CYO | Incidence Rate per 1000 CYO |
|---|---|---|---|
| Overall all-cause hospitalization | 560 | 17 044 | 32.9 (30.2–35.7) |
| All-cause hospitalization by yeara | |||
| Year 1 | 170 | 5357 | 31.7 (27.2–36.9) |
| Year 2 | 188 | 6014 | 31.3 (27.1–36.1) |
| Year 3 | 202 | 5673 | 35.6 (31.0–40.9) |
| Age-specific incidence of hospitalization | |||
| <5 y | 216 | 4276 | 50.5 (44.0–57.7) |
| 5–9 y | 195 | 6867 | 28.4 (24.6–32.7) |
| 10–15 y | 149 | 5901 | 25.3 (21.4–29.7) |
| Sex-specific incidence of hospitalization | |||
| Male | 307 | 8677 | 35.4 (31.6–39.6) |
| Female | 253 | 8367 | 30.2 (26.7–34.2) |
| Socioeconomic statusb | |||
| Low | 396 | 11 882 | 33.3 (30.2–36.8) |
| Middle | 140 | 4538 | 30.8 (26.1–36.4) |
| High | 17 | 508 | 33.5 (20.8–53.8) |
| Hospitalization for common morbidities, top 5 infectious causes (n = 342) | |||
| Acute undifferentiated fevers | 106 | 17 044 | 6.2 (5.1–7.5) |
| Respiratory tract infections | 94 | 17 044 | 5.5 (4.5–6.7) |
| Acute gastroenteritis | 65 | 17 044 | 3.8 (2.9–4.9) |
| Enteric fever | 50 | 17 044 | 2.9 (2.2–3.9) |
| Dengue fever | 27 | 17 044 | 1.6 (1.0–2.3) |
Abbreviations: CI, confidence interval; CYO, child-years of observation.
aYear 1 = October 2016–October 2017; year 2 = November 2017–October 2018; year 3 = November 2018–October 2019.
bData on socioeconomic status missing for 7 data points.
Figure 1.Causes of hospitalization in the Vellore cohort between 2016 and 2019 (n = 560). aIncludes infections of genitourinary system, viral hepatitis, mumps, meningitis, skin infections, tuberculosis, and other infectious conditions. bIncludes seizure disorders, poisoning, renal diseases, and others.
Figure 2.Year-wise distribution of top 5 infectious causes of hospitalization between 2016 and 2018 (n = 342). Year 1 = October 2016–October 2017; year 2 = November 2017–October 2018; year 3 = November 2018–October 2019.
Hospital Facility Utilized and Duration of Hospitalization in the Cohort (n = 560)
| Health Care Facility | Value |
|---|---|
| Secondary-care facilitya (n = 360) | |
| Government secondary-care hospital | 180 (32) |
| CHADb | 91 (16.3) |
| LCECUb | 63 (11.3) |
| Private hospital | 26 (4.6) |
| Tertiary-care facilityc (n = 189) | |
| CMCb | 106 (18.9) |
| Government tertiary-care and referral hospital | 77 (13.8) |
| Private hospital | 6 (1.1) |
| Hospitalization in more than a single facility for an episode of illness | 11 (2) |
| Duration of hospitalization, d, median (IQR) | 4 (3–6) |
Data are No. (%) except where indicated.
Abbreviations: CHAD, Community Health and Development; CMC, Christian Medical College; IQR, interquartile range; LCECU, Low-Cost Effective Care Unit.
aSecondary-care facility: A hospital serving a population of 100 000 in a defined geographical area and serves as the first referral center from a primary health care facility.
bNot-for-profit private organization.
cTertiary-care facility: Medical college/multispeciality hospitals that are the highest referral centers from primary and secondary health facilities.
Figure 3.Cumulative distribution of top 5 infectious causes for hospitalization, between 2016 and 2019 represented by month, showing seasonal patterns (n = 342).
Direct Medical Costsa of Fever-Related Hospitalizations Incurred at Different Health Facilities (n = 158/560b,d)
| nc | Investigation Costs | Inpatient Costs Inclusive of Consumables | Medication Costs | nd | Total Costs Incurred Towards Hospitalization | |
|---|---|---|---|---|---|---|
| Total | 151 | 1625 (570–2817) | 1050 (240–1710) | 1247 (791–2130) | 158 | 4243 (2502–7215) |
|
| ||||||
| Facility | ||||||
| CMCe | 45 | 2426 (1270–4160) | 2135 (1050–5565) | 3031 (1334–4462) | 45 | 9630 (5070–13 879) |
| CHADe | 69 | 1350 (740–2170) | 1090 (910–1450) | 972 (604–1414) | 69 | 3507 (2586–4878) |
| LCECUe | 31 | 667 (0–2027) | 0 | 1013 (731–1428) | 31 | 1830 (1043–3021) |
| Hospitalization in more than a single facility for an episode of illness | 6 | 2223 (1895– 3830) | 3875 (1440–12 540) | 1680 (940–5231) | 6 | 15 445 (4312–26 001) |
| Private hospitals | 0 | … | … | … | 7 | 9000 (5000–22 000) |
|
| ||||||
| Cause | ||||||
| Acute undifferentiated fevers | 12 | 1509 (912–2422) | 570 (0–1223) | 1108 (736–1485) | 15 | 3860 (3052–6542) |
| Respiratory tract infections | 36 | 1039 (284–1613) | 873 (0–1753) | 995 (712–2013) | 36 | 2456 (1527–6723) |
| Acute gastroenteritis | 5 | 107 (0–1720) | 0 (0–490) | 1564 (928–1687) | 6 | 3475 (1687–7923) |
| Enteric fever | 36 | 1068 (60–2105) | 1160 (415–1450) | 1418 (990–2253) | 37 | 3507 (2825–5335) |
| Dengue fever | 18 | 2651 (1895–3330) | 1613 (1050–2855) | 1287 (761–2185) | 19 | 5627 (4357–11 536) |
Data are median (IQR).
Abbreviations: CHAD, Community Health and Development; CMC, Christian Medical College; IQR, interquartile range; LCECU, Low-Cost Effective Care Unit.
aAll costs calculated in INR (Indian rupee rate).
bOf the 560 overall hospitalizations, data on direct medical costs for hospitalizations was available for 158 children; 371 hospitalizations did not have data on direct medical costs of which 258 hospitalizations were at government health facilities where treatment is free of cost and 113 admissions were at health facilities of CMC and other private hospitals for which medical bills were not available. Additionally, 31 hospitalizations for which data on direct medical costs were available were not considered for this analysis as these hospitalizations were surgery-related (17), trauma (5), congenital (3), malignancy (2), chronic diseases (2), tonsillitis associated without fever (1), and seizure disorder (1).
cIncludes those records with individual medical bills available for calculation of direct medical costs.
dDerived from medical bills available as well as history from primary caregiver for bills that were not available.
eNot-for-profit organization.
Antibiotic Prescription During Hospitalization (n = 560)
| Prescription | na (%) | Median No. of Antibiotics Used (IQR) |
|---|---|---|
| No. of antibiotics | ||
| Hospitalizations with antibiotics prescribed | 367/560 (65.5) | … |
| Children given 1 antibiotic | 152/367 (41.4) | … |
| Children given 2 antibiotics | 118/367 (32.2) | … |
| Children given 3 or more antibiotics | 97/367 (26.4) | … |
| Total number of antibiotics prescribed for the 367 hospitalizations | 713 | … |
| Commonly used antibiotics (n = 713b) | ||
| Beta-lactam groupc | 475 (66.6) | … |
| Amino glycosides | 81 (11.4) | … |
| Macrolides | 56 (7.9) | … |
| Tetracyclines | 38 (5.3) | … |
| Fluoroquinolones | 18 (2.5) | … |
| Othersd | 45 (6.3) | … |
| Top 5 infectious causes of hospitalizationse (n = 342) | ||
| Acute undifferentiated fevers | 72/106 (67.9) | 1 (0–2) |
| Respiratory tract infections | 80/94 (85.1) | 2 (1–3) |
| Acute gastroenteritis | 31/65 (47.7) | 0 (0–1) |
| Enteric feverf | 49/50 (98) | 2 (2–3) |
| Dengue fever | 16/27 (59.3) | 0 (0–1) |
Abbreviation: IQR, interquartile range.
aNumber of antibiotics prescribed among the number of hospitalization prescriptions retrieved during the surveillance.
bEvents are not exclusive of each other; includes children who were on multiple antibiotics.
cThird-generation cephalosporins were 321/475 (67.6%) antibiotic prescriptions.
dOthers included nitroimidazoles, glycopeptides, oxazolidinones, sulphonamides, first- and second-generation cephalosporins, polyenes, carbapenems, and nitrofuran.
eDiagnosis based on the final diagnosis mentioned in the discharge summary.
fThirty-five were blood culture confirmed, with the remaining 15 cases being diagnosed as clinical enteric fever.